In breast cancer, the reduced expression of E-cadherin has been reported in approximately 50% of invasive ductal carcinomas, whereas invasive lobular carcinomas showed complete loss of E-cadherin expression in nearly 90% of cases and have also been shown to contribute to metastasis. Here, CDH1 is linked to invasive ductal breast carcinoma.